Skip to main content

Table 5 Multivariate analyses of factors associated with disease severity, hospital length of stay, and mortality in study population (N=45,360)

From: Prevalence of hepatopancreatic injury and clinical outcomes in patients with COVID-19 in USA

Variables

Disease severity

Mortality

Length of stay

Critical vs mild/moderate

Severe vs mild/moderate

 

OR

95%CI

OR

95%CI

OR

95%CI

Coefficient

P value

Hepato-pancreatic injury

2.710

2.532–2.901

1.398

1.320–1.481

3.389

3.150–3.646

2.004

<0.0001

Age

1.029

1.027–1.031

1.026

1.024–1.028

1.065

1.063–1.068

− 0.068

<0.0001

Sex (male vs female)

1.370

1.284–1.461

1.156

1.092–1.224

1.177

1.110–1.248

0.494

<0.0001

Alcohol use

1.750

1.418–2.160

1.540

1.267–1.873

0.982

0.817–1.181

1.787

<0.0001

Liver cirrhosis

1.941

1.620–2.327

1.798

1.516–2.133

1.321

1.163–1.500

0.889

<0.0001